Zofran ODT Administration: On the Tongue
Zofran ODT (ondansetron orally disintegrating tablet) should be placed on top of the tongue, not administered sublingually. The tablet is designed to dissolve rapidly on the tongue surface and be swallowed with saliva. 1
Proper Administration Technique
The FDA-approved prescribing information provides explicit instructions for Zofran ODT administration: 1
- Remove the tablet with dry hands from the bottle or by peeling back the foil backing of the blister pack
- Do not push the tablet through the foil backing, as this can damage the tablet
- Immediately place the tablet on top of the tongue where it will dissolve in seconds
- Swallow with saliva after dissolution
- Administration with liquid is not necessary 1
Key Distinction: Oral vs. Sublingual
The formulation is specifically designed as an orally disintegrating tablet that disperses on the tongue surface, not a sublingual tablet that dissolves under the tongue. 1 The tablet rapidly disintegrates in approximately 60 seconds when placed on the tongue. 1
Clinical Context
This formulation was developed specifically for patients who have difficulty swallowing conventional tablets or who cannot tolerate drinking water, such as those with: 2
- Severe nausea and vomiting
- Tumors of the oral cavity, mouth, or esophagus
- Difficulty swallowing due to anatomical reasons
The on-tongue placement allows the medication to disperse in saliva and be swallowed naturally, making it particularly useful in oncology settings for chemotherapy- and radiotherapy-induced nausea. 3
Common Pitfall to Avoid
Do not instruct patients to place the tablet under the tongue (sublingually). This is incorrect and may reduce efficacy, as the formulation is designed for on-tongue dissolution followed by swallowing with saliva, not for sublingual absorption. 1